Bipolar disorder

Reach out to us today! Most Private Insurance Accepted

08-18   FDA approves long-acting injectable as treatment for bipolar disorder

The Food and Drug Administration (FDA) has approved the extended-release formulation of aripiprazole (Abilify Maintena) as an injectable suspension for maintenance monotherapy treatment of bipolar 1 disorder (BP-1) in adults. Abilify Maintena is an atypical antipsychotic, developed jointly by Otsuka Pharmaceutical Co, Ltd, in Japan and H. Lundbeck A/S, a Danish international pharmaceutical company. It […]

05-11   Mental Health Awareness Month: Thinning of gray matter in bipolar disorder patients responsible for its symptoms

Posted in Bipolar disorder

Millions of Americans each year are diagnosed with some kind of mental disorder, including depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), among others. According to the National Alliance on Mental Illness (NAMI), roughly 18.5 percent adults in the United States experience mental illness in any given year. Since 1949, every year […]

05-09   Online support program to help bipolar patients

Bipolar disorder is a mental illness marked by episodes of depression and mania, affecting 1 percent people across the world. Also known as manic-depressive illness, it is a brain disorder causing drastic upheavals in the mood, activity levels and energy, coupled with an impaired ability to accomplish mundane everyday chores. It is more prevalent among […]